Cain WS, Gent JF, Goodspeed RB, Leonard G Evaluation of olfactory dysfunction in the Connecticut Chemosensory Clinical Research Center. Laryngoscope. 1988 Jan;98(1):83-8.
Croy I, Nordin S, Hummel T Olfactory disorders and quality of life--an updated review. Chem Senses. 2014 Mar;39(3):185-94. doi: 10.1093/chemse/bjt072. Epub 2014 Jan 15. Review.
Doty RL, Frye RE, Agrawal U Internal consistency reliability of the fractionated and whole University of Pennsylvania Smell Identification Test. Percept Psychophys. 1989 May;45(5):381-4.
Doty RL, Shaman P, Dann M Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav. 1984 Mar;32(3):489-502.
Doty RL Office procedures for quantitative assessment of olfactory function. Am J Rhinol. 2007 Jul-Aug;21(4):460-73. Review.
Doty RL Olfaction in Parkinson's disease and related disorders. Neurobiol Dis. 2012 Jun;46(3):527-52. doi: 10.1016/j.nbd.2011.10.026. Epub 2011 Dec 20. Review.
Doty RL Olfactory dysfunction and its measurement in the clinic. World J Otorhinolaryngol Head Neck Surg. 2015 Oct 26;1(1):28-33. doi: 10.1016/j.wjorl.2015.09.007. eCollection 2015 Sep. Review.
Dunlop BW, Gray J, Rapaport MH Transdiagnostic Clinical Global Impression Scoring for Routine Clinical Settings. Behav Sci (Basel). 2017 Jun 27;7(3). pii: E40. doi: 10.3390/bs7030040.
Fleiner F, Lau L, Göktas Ö Active olfactory training for the treatment of smelling disorders. Ear Nose Throat J. 2012 May;91(5):198-203, 215.
Frasnelli J, Hummel T Olfactory dysfunction and daily life. Eur Arch Otorhinolaryngol. 2005 Mar;262(3):231-5. Epub 2004 May 5.
Geißler K, Reimann H, Gudziol H, Bitter T, Guntinas-Lichius O Olfactory training for patients with olfactory loss after upper respiratory tract infections. Eur Arch Otorhinolaryngol. 2014 Jun;271(6):1557-62. doi: 10.1007/s00405-013-2747-y. Epub 2013 Oct 6.
Harless L, Liang J Pharmacologic treatment for postviral olfactory dysfunction: a systematic review. Int Forum Allergy Rhinol. 2016 Jul;6(7):760-7. doi: 10.1002/alr.21727. Epub 2016 Feb 16. Review.
Hedner M, Larsson M, Arnold N, Zucco GM, Hummel T Cognitive factors in odor detection, odor discrimination, and odor identification tasks. J Clin Exp Neuropsychol. 2010 Dec;32(10):1062-7. doi: 10.1080/13803391003683070. Epub 2010 Apr 30.
Hoffman HJ, Rawal S, Li CM, Duffy VB New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunction. Rev Endocr Metab Disord. 2016 Jun;17(2):221-40. doi: 10.1007/s11154-016-9364-1. Review.
Hugh SC, Siu J, Hummel T, Forte V, Campisi P, Papsin BC, Propst EJ Olfactory testing in children using objective tools: comparison of Sniffin' Sticks and University of Pennsylvania Smell Identification Test (UPSIT). J Otolaryngol Head Neck Surg. 2015 Mar 1;44:10. doi: 10.1186/s40463-015-0061-y.
Isaiah A, Vongpaisal T, King AJ, Hartley DE Multisensory training improves auditory spatial processing following bilateral cochlear implantation. J Neurosci. 2014 Aug 13;34(33):11119-30. doi: 10.1523/JNEUROSCI.4767-13.2014.
Marine N, Boriana A Olfactory markers of depression and Alzheimer's disease. Neurosci Biobehav Rev. 2014 Sep;45:262-70. doi: 10.1016/j.neubiorev.2014.06.016. Epub 2014 Jul 6. Review.
Neuland C, Bitter T, Marschner H, Gudziol H, Guntinas-Lichius O Health-related and specific olfaction-related quality of life in patients with chronic functional anosmia or severe hyposmia. Laryngoscope. 2011 Apr;121(4):867-72. doi: 10.1002/lary.21387. Epub 2011 Feb 4.
Pekala K, Chandra RK, Turner JH Efficacy of olfactory training in patients with olfactory loss: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2016 Mar;6(3):299-307. doi: 10.1002/alr.21669. Epub 2015 Dec 1. Review.
Quint C, Temmel AF, Schickinger B, Pabinger S, Ramberger P, Hummel T Patterns of non-conductive olfactory disorders in eastern Austria: a study of 120 patients from the Department of Otorhinolaryngology at the University of Vienna. Wien Klin Wochenschr. 2001 Jan 15;113(1-2):52-7.
Runnebaum B, Runnebaum H, Stöber I, Zander J Progesterone 20 alpha-dihydroprogesterone and 20 beta-dihydroprogesterone levels in different compartments from the human foeto-placental unit. Acta Endocrinol (Copenh). 1975 Nov;80(3):558-68.
Seiden AM, Duncan HJ The diagnosis of a conductive olfactory loss. Laryngoscope. 2001 Jan;111(1):9-14.
Seiden AM Postviral olfactory loss. Otolaryngol Clin North Am. 2004 Dec;37(6):1159-66. Review.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.